You are here

  1. Home
  2. Dr Terry Bilverstone

Dr Terry Bilverstone

Profile summary

Web links

Professional biography

Biography

Terry Bilverstone is a Lecturer in Biomedical Sciences (Clinical Microbiology). He was awarded his PhD on the virulence of Clostridioides difficile, in 2019 from the University of Nottingham, UK. His research focuses on the application of engineering biology principles, to develop alternative antimicrobial agents for combatting the pathogenic clostridia. Terry researches the function and genetic regulation of clostridial toxins, in order to direct the development of anti-virulence strategies thereto. He also conducts research into the genetic engineering of bacteriophages (phages), to enhance their potential as therapeutic agents.  

The Anaerobes in Medicine, AiM Lab

Terry is the principal investigator of the Anaerobes in Medicine, AiM Lab which is equipped with a class-leading A95 Anaerobic Workstation (Don Whitley Scientific). This equipment facilitates the manipulation of microorganisms under stritcly controlled anaerobic conditions. 

Editorial

Terry is a Junior Editor for Letters in Applied Microbiology - a flagship journal of Applied Microbiology International. 

Research interests

Understanding C. difficile toxin biology.

Isolating novel phages infecting C. difficile.

Engineering phages with enhanced therapeutic properties.

Developing alternative antimicrobial agents to combat the pathogenic clostridia.

Teaching interests

Clinical microbiology

Molecular microbiology

Infection biology

Antimicrobial resistance 

Externally funded projects

Fabrication and assessment of smart wound dressings to promote diabetic wound healing using electrospinning
RoleStart dateEnd dateFunding source
Co-investigator01 Apr 202431 Mar 2025British Council

Diabetic wound healing is a serious public health problem encountering diabetic patients worldwide. It can lead to terrible consequences, such as gangrene or amputation, if not treated correctly and quickly. The delay of diabetic wound healing is due to contamination of diabetic wounds with resistant bacterial strains that tend to keep wound site at alkaline pH (pH≥8). Therefore, with the absence of adequate antimicrobial agent, there is a high demand to find alternative, effective and safe antimicrobial agents. Iron oxide nanoparticles (IONPs) was reported to have a broad-spectrum antimicrobial activity where its principle antimicrobial mechanism involves the production of reactive oxygen species (ROS) that are able to attach the micro-organism at multiple sites and thus reduce the potential of micro-organism developing resistance. Moreover, it has a good safety profile being approved by FDA for treatment of hemolytic anemia. In the current project, a cutting-edge science, will use electrospinning techniques to fabricate a smart wound dressing where IONPs will be incorporated into pH-responsive polymeric nanofibers (Eudragit L100) followed by investigating its antimicrobial activity (in-vitro) against the common causative bacteria associated with wound infections. This will be followed by assessing the cytotoxicity of produced smart wound dressing both in vitro (Human dermal fibroblast cells) and in vivo (acute and sub-chronic toxicity). Then after, assessing the wound healing capacity of produced smart wound dressing on infected and non-infected wound of diabetic animal model in comparison to a selected wound dressing available in market. The obtained results will be correlated with future pilot clinical study as a further test of their suitability to progress to clinical translation targeting chronic wound treatment in diabetic patients. Such developed smart wound dressing would be of interest to Egypt & other developing countries where human resources & healthcare budgets are limited. Produced locally, these smart wound dressing will be a revenue source & enhance the socio-economic development of Egypt and other ODA-supported countries. The is a collaborative project with Dr Yasmin Abozeid (Associate Professor, School of Pharmacy, Helwan University, Cairo. Egypt).

Publications

Clostridioides difficile Binary Toxin Binding Component Increases Virulence in a Hamster Model (2023-01-31)
Simpson, Morgan; Bilverstone, Terry; Leslie, Jhansi; Donlan, Alexandra; Uddin, Md Jashim; Petri, William A; Marin, Natasha; Kuehne, Sarah; Minton, Nigel P and Petri, William A
Open Forum Infectious Diseases, 10(3)


A Novel Bacteriophage with Broad Host Range against Clostridioides difficile Ribotype 078 Supports SlpA as the Likely Phage Receptor (2022-02-02)
Whittle, M. J.; Bilverstone, T. W.; van Esveld, R. J.; Lücke, A. C.; Lister, M. M.; Kuehne, S. A.; Minton, N. P. and Auchtung, Jennifer M.
Microbiology Spectrum, 10(1)


What's a SNP between friends: The lineage of Clostridioides difficile R20291 can effect research outcomes (2021-07-31)
Monteford, Jorge; Bilverstone, Terry W.; Ingle, Patrick; Philip, Sheryl; Kuehne, Sarah A. and Minton, Nigel P.
Anaerobe, 71, Article 102422


The glucosyltransferase activity of C. difficile Toxin B is required for disease pathogenesis (2020)
Bilverstone, Terry W.; Garland, Megan; Cave, Rory J.; Kelly, Michelle L.; Tholen, Martina; Bouley, Donna M.; Kaye, Philip; Minton, Nigel P.; Bogyo, Matthew; Kuehne, Sarah A. and Melnyk, Roman A.
PLOS Pathogens, 16, Article e1008852(9)


Phosphorylation and functionality of CdtR in Clostridium difficile (2019-07-19)
Bilverstone, T.W.; Minton, N.P. and Kuehne, S.A.
Anaerobe, 58 (pp. 103-109)


Development of Clostridium difficile R20291ΔPaLoc model strains and in vitro methodologies reveals CdtR is required for the production of CDT to cytotoxic levels (2017-01-17)
Bilverstone, T.W.; Kinsmore, N.L.; Minton, N.P. and Kuehne, S.A.
Anaerobe, 44 (pp. 51-54)


Manipulation of Conditions during Wort Collection in Production-Scale Fermentations to Regulate Volatile Ester Synthesis as an Aid to Product Matching for Multisite Brewing (2015)
Bilverstone, Terry W.; White, Rod and Boulton, Chris A.
Journal of the American Society of Brewing Chemists, 73(4) (pp. 347-353)


Engineering Clostridioides difficile phages for therapeutic use – identifying the potential repressor gene (2022-09)
Kerr, S.; Bilverstone, T.W. and Minton, N.P.
In : Phages: Bacteriophage in Medicine, Food and Biotechnology (05-06 Sep 2022, Oxford, United Kingdom.)


Phosphorylation and functionality of CdtR in Clostridium difficile (2018-07)
Bilverstone, T.W.; Minton, N.P. and Kuehne, S.A.
In : The 14th Biennial Congress of the Anaerobe Society of the Americas (09-12 Jul 2018, Las Vegas, Nevada, USA.)


CdtR (only) the regulator of binary toxin in Clostridium difficile (2016-07)
Bilverstone, T. W.; Kinsmore, N. L.; Minton, N. P. and Kuehne, S. A.
In : The 13th Biennial Congress of the Anaerobe Society of the Americas (11-14 Jul 2016, Tennessee, USA.)


Construction and Characterisation of CDR20291 ΔPaLoc Model Strains for the Study of Binary Toxin Regulation in Clostridium difficile. (2016-03)
Bilverstone, Terry; Kinsmore, Natasha; Minton, Nigel and Kuehne, Sarah
In : Microbiology Society Annual Conference 2016 (21-24 Mar 2016, Liverpool, UK.)


A laboratory-scale fermentation system and its application to developing predictable regimes for the control of volatile ester formation at production scale (2013-05)
Bilverstone, Terry W.; Boulton, Chris A. and White, Rod
In : 2013 ASBC Annual Meeting (19-22 May 2013, Tucson, Arizona, USA.)